Original filing (PDF)20230131091330NAL0021754768001

Antares Pharma, Inc.

Name: Antares Pharma, Inc. — Antares Pharma, Inc. Employee, Form 5500 (2022)
Creator: Antares Pharma, Inc.
License: https://www.usa.gov/government-works

Form 5500

FILING_RECEIVED

Antares Pharma, Inc. Employee Savings Plan

401(k) retirement plan · Antares Pharma, Inc.'s Antares Pharma, Inc. Employee Savings Plan filed a Form 5500 for plan year 2022, with Newport Group as recordkeeper.

Signals · 2

Late participant contributionsCorrective distributions issued

Active participants

Accounts w/ balance

Plan assets (EOY)

Net assets (EOY)

People on this filing

Kyle Gager signed Antares Pharma, Inc.'s 2022 Form 5500 as plan administrator.

Kyle Gager — Plan Administrator — Form 5500 signer

Get verified email & phone for these signers

Signer names are public record from the Form 5500 e-signature.

Plan identifiers

Antares Pharma, Inc.'s EIN is 41-1350192.

EIN 41-1350192

Plan number 001

Plan year 2022

ACK ID 20230131091330NAL0021754768001

Official Form 5500 document

Download the official 2022 Form 5500 (PDF) for Antares Pharma, Inc. from the U.S. Department of Labor's EFAST2 system.

Download the official 2022 Form 5500 (PDF)

Plan features

Antares Pharma, Inc.'s plan includes profit-sharing, ERISA 404(c) participant direction, a 401(k) feature, a default investment (QDIA).

Decision-maker contacts

One unlock reveals every key decision-maker — plan signer, CFO, HR & Benefits — with verified email + LinkedIn for ANTARES PHARMA, INC..

Finding similar companies…

How this plan invests

This plan

1 collective trust

Schedule D

Individual securities

on each trust's filing

This plan doesn't hold securities directly — it invests through trusts. Click a trust below to drill into its securities.

Plan health score

Top-tier plan health

Directional indicator from public Form 5500 data — compliance & integrity, total plan cost, participant health and vendor stack, benchmarked against same-size peers. Not a fiduciary tool. Based on 50% of scoring inputs for this filing.

Compliance & integrity

Total plan cost

n/a

Plan health

n/a

Vendor & structure

100

Knocking points off

Delinquent participant contributions reported (Schedule H 4a) — 48K (3% of contributions).
Corrective distributions issued (likely failed ADP/ACP testing).

Helping the score

Cost not scored — no comparable Schedule H expense data for this cohort.
Plan health not scored — no comparable participation/contribution data.

Plan sponsor

Name

ANTARES PHARMA, INC.

EIN

all filings

Address

100 PRINCETON SOUTH · SUITE 300 · EWING, NJ · 08628

Phone

(609) 359-3020

Industry

Manufacturing

Plan administrator

Same as plan sponsor.

Plan characteristics

Plan number

001

Plan year

2022

Plan year begin

2022-01-01

Tax period

2022-11-30

Filed

2023-01-31

Pension benefit codes

2E · Profit-sharing

2F · ERISA section 404(c)

2G · Total participant-directed accounts

2J · 401(k) feature

2K · 401(m) arrangement

2T · Default investment account (QDIA)

3D · Pre-approved plan (master / prototype / VS)

3F · Sponsor used leased employees

Service providers (Schedule C)

2 rows

Recordkeeper

Name	EIN	Location	Relation	Direct comp	Indirect comp
NEWPORT GROUP, INC.	27-2037969	—	RECORD-KEEPER	$26K	—

Advisor / Consultant

Name	EIN	Location	Relation	Direct comp	Indirect comp
CAP TRUST FINANCIALS	—	RALEIGH, NC	ADVISOR	$21K	—

Investments

1 pooled fund· $0

Rows tagged as a trust or pooled fund hold many underlying securities. Click one to drill into its own Schedule of Assets — where the individual funds, shares, and CUSIPs live.